B. Riley Financial’s Pfizer PFE Stock Holding History

B. Riley Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,428	Closed	-$227K	–	172
2018 Q3	$227K	Sell	5,428 -12,631	-70%	-$486K	0.06%	161
2018 Q2	$636K	Sell	18,059 -3,356	-16%	-$115K	0.17%	114
2018 Q1	$721K	Buy	21,415 +3,408	+19%	+$117K	0.2%	118
2017 Q4	$619K	Sell	18,007 -2,198	-11%	-$74.9K	0.16%	139
2017 Q3	$684K	Buy	+20,205	New	+$649K	0.19%	134
2017 Q2	–	Sell	-6,942	Closed	-$225K	–	224
2017 Q1	$225K	Sell	6,942 -421	-6%	-$13.3K	0.11%	133
2016 Q4	$227K	Sell	7,363 -116	-2%	-$3.54K	0.15%	124
2016 Q3	$240K	Hold	7,479	–	–	0.15%	97
2016 Q2	$250K	Hold	7,479	–	–	0.14%	87
2016 Q1	$210K	Sell	7,479 -1,291	-15%	-$36.9K	0.15%	107
2015 Q4	$269K	Buy	+8,770	New	+$276K	0.19%	87

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

B. Riley Financial's PFE Position: Q4 2018 in Review

B. Riley Financial sold out of Pfizer (PFE) in Q4 2018, closing a stake of 5,428 shares — an estimated $227K sold.

B. Riley Financial first reported a position in PFE in Q4 2015 and held it in 11 quarters. The position peaked at $721K in Q1 2018. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

B. Riley Financial reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
B. Riley Financial sold 5,428 Pfizer shares in Q4 2018, an estimated $227K.
B. Riley Financial first reported a position in Pfizer in Q4 2015 and held it in 11 quarters.
B. Riley Financial's Pfizer position peaked at $721K in Q1 2018.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on B. Riley Financial's 13F filing for Q4 2018, filed 7 Feb 2019.